C. C. Johansson

发表

Higher Antioxidative Capacity Than the Produced by Activated Granulocytes and Has Resistant to Reactive Oxygen Species CD56bright NK Cell Subset Is - The CD16

R. Kiessling, D. Sakurai, H. Norell, 2013 .

The CD16 CD56 NK Cell Subset Is Resistant to Reactive Oxygen Species Produced by Activated Granulocytes and Has Higher Antioxidative Capacity Than the CD16 CD56 Subset

R. Kiessling, D. Sakurai, H. Norell, 2007 .

The CD16−CD56bright NK Cell Subset Is Resistant to Reactive Oxygen Species Produced by Activated Granulocytes and Has Higher Antioxidative Capacity Than the CD16+CD56dim Subset1

R. Kiessling, K. Malmberg, D. Sakurai, 2007, The Journal of Immunology.

Naturally occurring regulatory T cells show reduced sensitivity toward oxidative stress-induced cell death.

D. Mougiakakos, R. Kiessling, C. C. Johansson, 2009, Blood.

Oxidative Stress Catalase Protects Human T Cells against Transduction with the Antioxidant Enzyme

D. Mougiakakos, M. Nishimura, R. Kiessling, 2008 .

High expression of GCLC is associated with malignant melanoma of low oxidative phenotype and predicts a better prognosis

D. Mougiakakos, C. Blank, R. Kiessling, 2012, Journal of Molecular Medicine.

T cell recognition of HLA‐A2 restricted tumor antigens is impaired by the oncogene HER2

B. Seliger, D. Mougiakakos, M. Nishimura, 2011, International journal of cancer.

FOXP3+CD4+CD25+ Adaptive Regulatory T Cells Express Cyclooxygenase-2 and Suppress Effector T Cells by a Prostaglandin E2-Dependent Mechanism1

E. Aandahl, K. Taskén, M. Mahic, 2006, The Journal of Immunology.

The impact of inﬂammatory licensing on heme oxygenase-1–mediated induction of regulatory T cells by human mesenchymal stem cells

D. Mougiakakos, R. Jitschin, R. Kiessling, 2011 .

Multipotent Mesenchymal Stromal Cells Express FoxP3: A Marker for the Immunosuppressive Capacity?

D. Mougiakakos, A. Barrett, R. Kiessling, 2011, Journal of immunotherapy.

Dependent Mechanism 2 Effector T Cells by a Prostaglandin E SuppressCells Express Cyclooxygenase-2 and Adaptive Regulatory T + CD 25 + CD 4 + FOXP 3 Taskén and

E. Aandahl, K. Taskén, M. Mahic, 2006 .

Increased thioredoxin-1 production in human naturally occurring regulatory T cells confers enhanced tolerance to oxidative stress.

D. Mougiakakos, R. Jitschin, R. Kiessling, 2011, Blood.

A Winged Helix Forkhead (FOXD2) Tunes Sensitivity to cAMP in T Lymphocytes through Regulation of cAMP-dependent Protein Kinase RIα*

S. Enerbäck, S. R. Blomqvist, E. Aandahl, 2003, The Journal of Biological Chemistry.

Cytokine networks are pre-activated in T cells from HIV-infected patients on HAART and are under the control of cAMP

K. Taskén, S. Frøland, P. Aukrust, 2004, AIDS.

Expression and prognostic significance of iNOS in uveal melanoma

O. Larsson, D. Mougiakakos, R. Kiessling, 2010, International journal of cancer.

Nuclear HER3 is associated with favorable overall survival in uveal melanoma

O. Larsson, D. Mougiakakos, R. Kiessling, 2012, International journal of cancer.

Oxidative stress and lymphocyte persistence: implications in immunotherapy.

D. Mougiakakos, S. Mehrotra, R. Kiessling, 2009, Advances in cancer research.

Oxidative stress and lymphocyte persistence: implications in immunotherapy.

D. Mougiakakos, S. Mehrotra, R. Kiessling, 2009, Advances in cancer research.

Transduction with the Antioxidant Enzyme Catalase Protects Human T Cells against Oxidative Stress1

D. Mougiakakos, M. Nishimura, R. Kiessling, 2008, The Journal of Immunology.

The epidermal growth factor-like growth factor amphiregulin is strongly induced by the adenosine 3',5'-monophosphate pathway in various cell types.

K. Taskén, P. Aukrust, J. Enserink, 2004, Endocrinology.

The CD16- CD56(bright) NK cell subset is resistant to reactive oxygen species produced by activated granulocytes and has higher antioxidative capacity than the CD16+ CD56(dim) subset.

R. Kiessling, K. Malmberg, D. Sakurai, 2007, Journal of immunology.

Regulatory T cells in cancer.

D. Mougiakakos, R. Kiessling, A. Choudhury, 2010, Advances in cancer research.

Immune modulatory effects of cyclooxygenase type 2 inhibitors in HIV patients on combination antiretroviral treatment

E. Aandahl, K. Taskén, S. Frøland, 2006, AIDS.

B . Renaissance Through Steady Characterization

D. Mougiakakos, R. Kiessling, A. Choudhury, 2010 .

Intratumoral forkhead box P3‐positive regulatory T cells predict poor survival in cyclooxygenase‐2–positive uveal melanoma

O. Larsson, D. Mougiakakos, R. Kiessling, 2010, Cancer.

The impact of inflammatory licensing on heme oxygenase-1-mediated induction of regulatory T cells by human mesenchymal stem cells.

D. Mougiakakos, R. Jitschin, R. Kiessling, 2011, Blood.

Functional Gap Junctions Facilitate Melanoma Antigen Transfer and Cross-Presentation between Human Dendritic Cells1

R. Kiessling, D. Mandakovic, J. Sáez, 2007, The Journal of Immunology.

Dendritic Cells Cross-Presentation between Human Melanoma Antigen Transfer and Functional Gap Junctions Facilitate and

R. Kiessling, D. Mandakovic, J. Sáez, 2007 .

Comparative Expression Profiling of Distinct T Cell Subsets Undergoing Oxidative Stress

B. Seliger, D. Mougiakakos, R. Kiessling, 2012, PloS one.

High expression of GCLC is associated with malignant melanoma of low oxidative phenotype and predicts a better prognosis

D. Mougiakakos, C. Blank, R. Kiessling, 2012, Journal of Molecular Medicine.

Response:Resistance of naturally occurring regulatory T cells toward oxidative stress: possible link with intracellular catecholamine content and implications for cancer therapy

D. Mougiakakos, R. Kiessling, C. C. Johansson, 2009 .

Prognostic significance of tumor iNOS and COX-2 in stage III malignant cutaneous melanoma

D. Mougiakakos, R. Kiessling, J. Hansson, 2009, Cancer Immunology, Immunotherapy.

T cell recognition of HLA‐A2 restricted tumor antigens is impaired by the oncogene HER2

B. Seliger, D. Mougiakakos, M. Nishimura, 2011, International journal of cancer.

Naturally occurring regulatory T cells show reduced sensitivity toward oxidative stress-induced cell death.

D. Mougiakakos, R. Kiessling, C. C. Johansson, 2009, Blood.

Treatment with type-2 selective and non-selective cyclooxygenase inhibitors improves T-cell proliferation in HIV-infected patients on highly active antiretroviral therapy

E. Aandahl, K. Taskén, S. Frøland, 2004, AIDS.